Anti-(homo Sapiens Ms4a1 (membrane-spanning 4-domains Subfamily A Member 1 Uses, Dosage, Side Effects and more
Anti-(homo Sapiens Ms4a1 (membrane-spanning 4-domains Subfamily A Member 1 is under investigation in clinical trial NCT02772822 (A Study Comparing the Efficiency and Safety of S-chop(cyclophosphamide, Hydroxydaunomycin, Oncovin, and Prednisone) Versus R-CHOP in Untreated Cd20(cluster of Differentiation Antigen 20)-positive DLBCL Patients).
| Trade Name | Anti-(homo Sapiens Ms4a1 (membrane-spanning 4-domains Subfamily A Member 1 |
| Generic | Ripertamab |
| Ripertamab Other Names | Immunoglobulin g1-kappa, anti-(homo sapiens ms4a1 (membrane-spanning 4-domains subfamily a member 1, cd20)), chimeric monoclonal antibody, Immunoglobulin igg1, anti-(human cd20 antigen) (human-mus musculus monoclonal disulfide sct400 .gamma.1-chain), disulfide with human-mus musculus monoclonal sct400 .kappa.-chain, dimer, Ripertamab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
